Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Treatment of disorders characterized by reversible airway obstruction in childhood: are anti-cholinergic agents the answer?

Quizon A, Colin AA, Pelosi U, Rossi GA.

Curr Pharm Des. 2012;18(21):3061-85. Review.

PMID:
22564300
2.

Muscarinic acetylcholine receptors and airway diseases.

Coulson FR, Fryer AD.

Pharmacol Ther. 2003 Apr;98(1):59-69. Review.

PMID:
12667888
3.

Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease.

Belmonte KE.

Proc Am Thorac Soc. 2005;2(4):297-304; discussion 311-2. Review.

PMID:
16267352
4.

Beta2-agonist and anticholinergic drugs in the treatment of lung disease.

Proskocil BJ, Fryer AD.

Proc Am Thorac Soc. 2005;2(4):305-10; discussion 311-2. Review.

PMID:
16267353
5.

[Regulation of bronchial tone in chronic obstructive pulmonary disease (COPD): role of muscarinic receptors].

Abad Santos F, Novalbos J, Gallego Sandín S, Gálvez Múgica MA.

An Med Interna. 2003 Apr;20(4):201-5. Review. Spanish.

PMID:
12768836
6.

[Tiotropium as a controller of bronchoconstriction].

Lubiński W.

Pol Merkur Lekarski. 2004 May;16 Suppl 1:75-6, 78. Review. Polish.

PMID:
15524023
7.

Effects of inflammatory cells on neuronal M2 muscarinic receptor function in the lung.

Fryer AD, Adamko DJ, Yost BL, Jacoby DB.

Life Sci. 1999;64(6-7):449-55. Review.

PMID:
10069509
8.

Selective muscarinic receptor antagonists for airway diseases.

Lee AM, Jacoby DB, Fryer AD.

Curr Opin Pharmacol. 2001 Jun;1(3):223-9. Review.

PMID:
11712743
9.

Interaction of nondepolarizing muscle relaxants with M2 and M3 muscarinic receptors in guinea pig lung and heart.

Okanlami OA, Fryer AD, Hirshman C.

Anesthesiology. 1996 Jan;84(1):155-61.

PMID:
8572329
10.

Muscarinic receptor subtypes in airways.

Barnes PJ.

Life Sci. 1993;52(5-6):521-7. Review.

PMID:
8441331
11.

Muscarinic pharmacology of the airways.

Maclagan J, Barnes PJ.

Trends Pharmacol Sci. 1989 Dec;Suppl:88-92. Review.

PMID:
2694531
12.

Role of the parasympathetic nervous system and of cholinergic mechanisms in bronchial hyperreactivity.

Hahn HL.

Bull Eur Physiopathol Respir. 1986;22 Suppl 7:112-42. Review.

PMID:
3006841
13.

Eosinophil recruitment to the airway nerves.

Jacoby DB, Costello RM, Fryer AD.

J Allergy Clin Immunol. 2001 Feb;107(2):211-8. Review.

PMID:
11174183
14.

Eosinophils and airway nerves in asthma.

Costello RW, Jacoby DB, Gleich GJ, Fryer AD.

Histol Histopathol. 2000 Jul;15(3):861-8. Review.

PMID:
10963130
15.

Double-stranded RNA causes airway hyperreactivity and neuronal M2 muscarinic receptor dysfunction.

Bowerfind WM, Fryer AD, Jacoby DB.

J Appl Physiol (1985). 2002 Apr;92(4):1417-22.

PMID:
11896005
16.

Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease.

Barnes PJ, Belvisi MG, Mak JC, Haddad EB, O'Connor B.

Life Sci. 1995;56(11-12):853-9. Review.

PMID:
10188785
18.

Effect of tiotropium bromide on airway remodeling in a chronic asthma model.

Kang JY, Rhee CK, Kim JS, Park CK, Kim SJ, Lee SH, Yoon HK, Kwon SS, Kim YK, Lee SY.

Ann Allergy Asthma Immunol. 2012 Jul;109(1):29-35. doi: 10.1016/j.anai.2012.05.005. Epub 2012 May 25.

PMID:
22727154
20.

Muscarinic receptor subtypes: implications for therapy.

Barnes PJ.

Agents Actions Suppl. 1993;43:243-52. Review.

PMID:
8368167

Supplemental Content

Support Center